Trial Profile
Phase 1, multiple-dose study to evaluate the effect of AZD7986 (INS-1007) on neutrophil elastase (NE) activity in healthy volunteers
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 15 Nov 2017
Price :
$35
*
At a glance
- Drugs Brensocatib (Primary)
- Indications Chronic obstructive pulmonary disease
- Focus Adverse reactions; Therapeutic Use
- 15 Nov 2017 New trial record